Evaluation of the Effectiveness of Stimulation Cortex Sensorimotor for the Treatment of Rebel Neuropathic Pains
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Rebel Neuropathic Pains
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Enrollment
- 16
- Locations
- 1
- Primary Endpoint
- Efficacy of 50% of EVS at 3 weeks
- Status
- Terminated
- Last Updated
- 19 years ago
Overview
Brief Summary
The pains chronic neurogeneses remain difficult to treat whatever are their origin and their localization. The pharmacological therapeutic arsenal answers only partially the symptomatology often very invalidating which these chronic painful patients present. Electric stimulations of the central nervous system currently validated, in particular of the posterior cords of marrow made a significant improvement in a certain number of indications. Nevertheless, considerable patients are not relieved significantly, in particular those presenting of the pains neurogeneses of central origin (syndromes thalamic for example). It is within this framework that recently the stimulation of the sensorimotor cortex developed.
Principal objective: evaluation of the technique of stimulation under cortical on neuropathic pains .
Detailed Description
The pains chronic neurogeneses remain difficult to treat whatever are their origin and their localization. The pharmacological therapeutic arsenal answers only partially the symptomatology often very invalidating which these chronic painful patients present. Electric stimulations of the central nervous system currently validated, in particular of the posterior cords of marrow made a significant improvement in a certain number of indications. Nevertheless, considerable patients are not relieved significantly, in particular those presenting of the pains neurogeneses of central origin (syndromes thalamic for example). It is within this framework that recently the stimulation of the sensorimotor cortex developed.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Neurofibromatosis,
- •Rebel chronic neuropathic pain with duration \> 1 year and AVS \> = 4
Exclusion Criteria
- •Cognitive deterioration
Outcomes
Primary Outcomes
Efficacy of 50% of EVS at 3 weeks
Secondary Outcomes
- Efficacy of 50% of EVS at 6 months and 12 months